Accueil>>Proteins>> Growth Factors>> Macrophage Migration Inhibitory Factor>>Migrastatin

Migrastatin (Synonyms: (+)-Migrastatin)

Catalog No.GC48479

A fungal metabolite with antimuscarinic and anticancer activities

Products are for research use only. Not for human use. We do not sell to patients.

Migrastatin Chemical Structure

Cas No.: 314245-65-3

Taille Prix Stock Qté
1mg
1 071,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Migrastatin is a bacterial metabolite that has been found in Streptomyces with antimuscarinic and anticancer activities.1,2 It binds to M1-5 muscarinic acetylcholine receptors (Kis = >200, 200, 31, 43, and >200 µM, respectively) and inhibits calcium mobilization induced by carbamoylcholine in SK-N-SH cells (IC50 = 28 µM), as well as in primary rat bladder smooth muscle cells.1 Migrastatin inhibits the migration of EC17 esophageal cancer cells in a wound healing assay (IC50 = 10 µg/ml) and 4T1 mouse mammary carcinoma cells in a chamber cell migration assay (IC50 = 29 µM).2 It enhances cytotoxicity induced by vinblastine in vincristine-resistant P388/VCR cells.3

1.Nakae, K., Nishimura, Y., Ohba, S., et al.Migrastatin acts as a muscarinic acetylcholine receptor antagonistJ. Antibiot. (Tokyo)59(11)685-692(2006) 2.Reymond, S., and Cossy, J.Migrastatin and analogues: New anti-metastatic agentsC. R. Chim.11(11-12)1447-1462(2008) 3.Takemoto, Y., Tashiro, E., and Imoto, M.Suppression of multidrug resistance by migrastatinJ. Antibiot. (Tokyo)59(7)435-438(2006)

Avis

Review for Migrastatin

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Migrastatin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.